1 July MBS changes explained From chronic disease management to vitamin B12 testing, and COVID-19 support, significant item changes are now live.
Shingles vaccine linked to dementia risk reduction The new research found those vaccinated had their risk of new dementia diagnoses reduced by 20% over seven years.
Full details of incoming CDM changes revealed New MBS fees, transition arrangements and referral pathways have been unveiled. The RACGP President said he’s been left frustrated by the delay, but ‘at least we now have clarity’.
Should ADHD medications be stopped during pregnancy? A new study found dexamphetamine does not put mothers or their babies at risk, but stopping before conception could be beneficial for some.
Practical details of new bulk billing program revealed New DoHAC factsheets explain how the controversial incentives program will work, how GPs’ earnings could change, and accreditation exemptions.
‘Disappointing’: Bulk-billing loading allocation revealed The incentive will be split 50:50 between GPs and practices, but the RACGP has hit back, saying the Government ‘hasn’t listened’.
Detail of new women’s health MBS items explained With the items’ launch just days away, details of the menopause assessments have been released, including its rebates and mandatory clinical activities.
‘Breakthrough’ blood test for endometriosis: Study A new and non-invasive way to test early for the often-debilitating condition has been developed by Australian researchers.
New medication for treatment resistant depression added to PBS The nasal spray is available from 1 May to eligible patients, but a GP expert remains concerned about its accessibility.
How long does immunity last after a COVID infection? Dr Lara Herrero and Wesley Freppel assess the latest evidence, including the impact vaccination and emerging variants can have.